Work

Combined xCT and mTOR Inhibition as a New Therapeutic Option for Pancreatic Adenocarcinoma

Year: 2022

Type: article

Source: HPB

DOI: 10.1016/j.hpb.2022.05.658

Authors: K. Newcomer, D. Spitzer, L. Ross, K. Caldwell, S. Vangveravong, B. Van Tine, W. Hawkins

Institution: Washington University in St. Louis

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4312854592

FWCI:

Cites:

Cited by:

Related to: 10